Cargando…

Colchicine as a possible therapeutic option in COVID-19 infection

Detalles Bibliográficos
Autores principales:	Parra-Medina, Rafael, Sarmiento-Monroy, Juan Camilo, Rojas-Villarraga, Adriana, Garavito, Edgar, Montealegre-Gómez, Giovanni, Gómez-López, Arley
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2020
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7301347/ https://www.ncbi.nlm.nih.gov/pubmed/32556936 http://dx.doi.org/10.1007/s10067-020-05247-5

Ejemplares similares

Colchicine: A potential therapeutic tool against COVID-19. Experience of 5 patients
por: Montealegre-Gómez, Giovanni, et al.
Publicado: (2021)

Colchicine: A potential therapeutic tool against COVID-19. Experience of 5 patients
por: Montealegre-Gómez, Giovanni, et al.
Publicado: (2021)

Colchicine treatment in COVID-19: the remaining unsolved question
por: Rojas-Villarraga, Adriana, et al.
Publicado: (2021)

Familial Aggregation and Segregation Analysis in Families Presenting Autoimmunity, Polyautoimmunity, and Multiple Autoimmune Syndrome
por: Castiblanco, John, et al.
Publicado: (2015)

ASIA syndrome symptoms induced by gluteal biopolymer injections: Case-series and narrative review
por: Montealegre, Giovanni, et al.
Publicado: (2021)

Subcutaneous abatacept in rheumatoid arthritis: A real-life experience
por: Sarmiento-Monroy, Juan Camilo, et al.
Publicado: (2019)

Severe colchicine intoxication after self-administration of colchicine concomitantly with loxoprofen
por: Yamazaki, Akinori, et al.
Publicado: (2012)

Cardiovascular Disease in Rheumatoid Arthritis: A Systematic Literature Review in Latin America
por: Sarmiento-Monroy, Juan Camilo, et al.
Publicado: (2012)

Consensus Virtual Screening Protocol Towards the Identification of Small Molecules Interacting with the Colchicine Binding Site of the Tubulin‐microtubule System
por: López‐López, Edgar, et al.
Publicado: (2022)

Comments on “Fatal colchicine intoxication”
por: Amrollahi-Sharifabadi, Mohammad, et al.
Publicado: (2015)

Effects of colchicine on cardiac functions
por: Şener, Yusuf Ziya, et al.
Publicado: (2019)

COVID-19, colchicine and glycemia
por: Ilias, Ioannis, et al.
Publicado: (2021)

Cardiovascular Disease in Latin American Patients with Systemic Lupus Erythematosus: A Cross-Sectional Study and a Systematic Review
por: Amaya-Amaya, Jenny, et al.
Publicado: (2013)

Off‐target ACE2 ligands: Possible therapeutic option for CoVid‐19?
por: Brogi, Simone, et al.
Publicado: (2020)

Colchicine as a Potential Treatment Choice for COVID-19 Patients in Developing Countries: COVID-19 and Colchicine
por: Ghang, Byeongzu, et al.
Publicado: (2022)

Further reassurance on the safety profile of colchicine
por: Hashkes, Philip J.
Publicado: (2020)

Colchicine for COVID-19: Hype or hope?
por: Kow, Chia Siang, et al.
Publicado: (2022)

Treatment of acquired perforating dermatosis with colchicine
por: Kharghoria, Geetali, et al.
Publicado: (2022)

|Isolation and characterization of novel bacteriophages as a potential therapeutic option for Escherichia coli urinary tract infections
por: González-Villalobos, Edgar, et al.
Publicado: (2021)

Colchicine Intolerance: Does the Pharmaceutical Preparation Matter?
por: İlgen, Ufuk, et al.
Publicado: (2021)

Successful Treatment of Acquired Perforating Dermatosis with Colchicine
por: Gil, Francisco, et al.
Publicado: (2021)

Non-Cirrhotic Portal Hypertension in a Patient With Colonic Carcinoma Treated With Oxaliplatin
por: Fuentes-Lacouture, Maria Cynthia, et al.
Publicado: (2021)

Is Sildenafil a Therapeutic Option for Noncompaction?
por: Finsterer, Josef, et al.
Publicado: (2014)

Wells' Syndrome Successfully Treated with Colchicine
por: Puzas, Álvaro Iglesias, et al.
Publicado: (2017)

Colchicine and mortality outcomes in patients with coronavirus disease (COVID-19)
por: Danjuma, Mohammed I., et al.
Publicado: (2023)

Prevalence of Celiac Disease in Latin America: A Systematic Review and Meta-Regression
por: Parra-Medina, Rafael, et al.
Publicado: (2015)

Colchicine
por: Ben-Chetrit, Eldad
Publicado: (2018)

Microbioma, salud y enfermedad: probióticos, prebióticos y simbióticos
por: Gómez-López, Arley
Publicado: (2019)

Remdesivir as a possible therapeutic option for the COVID-19
por: Al-Tawfiq, Jaffar A., et al.
Publicado: (2020)

Possible Therapeutic Options for Complex Regional Pain Syndrome
por: Cha, Myeounghoon, et al.
Publicado: (2021)

Current and Possible Future Therapeutic Options for Huntington’s Disease
por: Ferguson, Mackenzie W., et al.
Publicado: (2022)

Pharmacologic therapeutic options for thromboprophylaxis in COVID-19
por: Kow, Chia Siang, et al.
Publicado: (2020)

Colchicine may not be effective in COVID-19 infection; it may even be harmful?
por: Cumhur Cure, Medine, et al.
Publicado: (2020)

Colchicine for the prevention of COVID-19 “hard” outcomes: All that glitters is not gold
por: Patoulias, Dimitrios, et al.
Publicado: (2022)

Colchicine plus Dapsone in Colchicine‐Resistant FMF Patients
por: Salehzadeh, Farhad, et al.
Publicado: (2019)

Comment on “Colchicine may not be effective in COVID-19 infection; it may even be harmful?”
por: Kobak, Senol
Publicado: (2020)

Colchicine May Interfere With the Efficacy of the Adenoviral Vector–Based Vaccine for COVID-19
por: Lin, Cheng-Wei
Publicado: (2022)

The Role of Radiotherapy Among the Therapeutic Options for Castleman’s Disease
por: Karaca, Feryal, et al.
Publicado: (2014)

COVID-19 therapeutic options for patients with kidney disease
por: Izzedine, Hassan, et al.
Publicado: (2020)

Poisoning by Colchicin
Publicado: (1890)

Cannot write session to /tmp/vufind_sessions/sess_lk81jv9fm4512viliht94qksnl